Course handouts are now available
Click here
Come to London
WATCH to find out why
Site updates:
Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.
Posters
(results will display both Free Papers & Poster)
Prostaglandin-associated periorbitopathy
Poster Details
First Author: A.Bayer TURKEY
Co Author(s): M. Kucukevcilioglu
Abstract Details
Purpose:
To investigate whether rates of prostaglandin-associated periorbitopathy (PAP) differ between bimatoprost (B), latanoprost (L), and travoprost (T) users.
Setting:
Gulhane Military Medical School, Department of Ophthalmology
Methods:
Sixty consecutive cases with glaucoma using one of the prostaglandins in one eye were evaluated for presence of components of PAP (enophthalmos, ptosis, upper eyelid sulcus deepening, involution of dermatochalasis, loss of periorbital fat pad). The contralateral eye was used as a control.
Results:
PAP was seen in 29 cases (48%). It was most frequent in patients using B (9/10), followed by T (9/12), and was less common in patients using L (11/38) (P = .00).
Conclusions:
PAP is more common in cases using B and T. This side effect seems to be worth considering, and patients should be informed when these drugs are prescribed FINANCIAL INTEREST: NONE
